October 21, 2019 Licensing, IP, and Legal

Sartorius Stedim Biotech signs agreement to acquire select Danaher Life Science platform businesses

Aubagne, October 21, 2019 The proposed transaction is part of the sale of a larger portfolio of businesses from Danaher to SSB’s major shareholder Sartorius Group Includes chromatography hardware and resins, and microcarriers (SoloHill) businesses Complements SSB’s strong position in the fast-growing bioprocessing market Agreement is subject to acquisition of the GE Biopharma business by... Read more

December 3, 2018 Clinical Research/Diagn.

Sartorius and Immunochina Partner to Advance Immunotherapy Development

December 03, 2018 02:00 AM Pacific Standard Time BEIJING–(BUSINESS WIRE)–Sartorius Stedim Biotech (SSB), a leading international supplier of the biopharmaceutical industry, through its China affiliate, and Beijing-based Immunochina Pharmaceuticals, announced today that both parties have entered into a collaboration. Under the terms of the relationship, Immunochina will gain preferred access to SSB’s bioprocess technology platform... Read more

June 11, 2018 M&A, Partnerships Process Analytical Instr.

Sartorius Stedim Biotech and Siemens sign long-term cooperation agreement in the area of automation

Siemens becomes a preferred supplier for automation solutions Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future New automated product to debut at the ACHEMA 2018 trade show in Frankfurt Göttingen | Munich, June 12, 2018 – The Siemens technology group and Sartorius Stedim Biotech (SSB), a leading... Read more

April 16, 2018 Acad, Gov/Utilities Bio/Pharma/CRO M&A, Partnerships

Sartorius Stedim Biotech and Penn State University announce partnership

University Park, Pennsylvania, USA | Goettingen, Germany, April 16, 2018 – Sartorius Stedim Biotech and Penn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. This long-term relationship will support the education and preparation of the next generation of biotechnology leaders. Part of Sartorius’ investment will be to... Read more

December 7, 2017 Informatics & Software Process Analytical Instr. Product Launch

Sartorius Stedim Biotech launches new versions of data analytics software solutions

The real-time monitoring and prediction system, SIMCA®-online, constantly monitors processes to provide a continuous snapshot of the users’ operations. SIMCA® and SIMCA®-online software updates in the UmetricsTM Suite help manufacturing industries make better business decisions and optimize process control Goettingen, Germany / Malmö, Sweden – December 07, 2017: Sartorius Stedim Biotech (SSB), a leading international... Read more

April 3, 2017 M&A, Partnerships

Sartorius Stedim Biotech (SSB) acquires leading biopharma software developer Umetrics

Leading data analytics software to optimize process development and production of biopharmaceuticals Swedish company already an SSB cooperation partner since 2012 2017 financial guidance confirmed Aubagne, April 3, 2017 – Sartorius Stedim Biotech, a leading supplier to the biopharma industry, today acquired the Umetrics business (MKS Instruments AB) from the U.S. based MKS Instruments Group.... Read more

April 3, 2017 M&A, Partnerships

MKS Announces Sale of Data Analytics Solutions Business to Sartorius Stedim Biotech

Andover, Mass., April 03, 2017 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ:MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced that it has completed the sale of its Data Analytics Solutions business to Sartorius Stedim Biotech (Euronext Paris:DIM), a leading supplier to the biopharmaceutical industry, for $72.5 million on... Read more